| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.181 | 7.397 | 12.563 | 10.458 | 12.470 | 11.630 | 13.813 | 15.543 | 10.113 | 15.568 |
| Total Income - EUR | 24.181 | 7.404 | 12.564 | 16.989 | 23.392 | 18.851 | 18.480 | 17.000 | 14.708 | 16.484 |
| Total Expenses - EUR | 27.158 | 16.577 | 17.055 | 16.665 | 17.778 | 16.937 | 15.699 | 16.532 | 13.552 | 19.319 |
| Gross Profit/Loss - EUR | -2.978 | -9.172 | -4.491 | 324 | 5.613 | 1.913 | 2.781 | 468 | 1.156 | -2.835 |
| Net Profit/Loss - EUR | -3.703 | -9.320 | -4.741 | 155 | 5.380 | 1.562 | 2.450 | 297 | 1.009 | -3.000 |
| Employees | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Topoprim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.386 | 1.991 | 9.615 | 6.337 | 3.891 | 1.674 | 0 | 0 | 696 | 519 |
| Current Assets | 2.941 | 1.242 | 1.335 | 1.181 | 558 | 1.284 | 1.955 | 1.284 | 579 | 1.194 |
| Inventories | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 108 |
| Receivables | 1.738 | 503 | 1.156 | 1.156 | 487 | 1.171 | 1.307 | 432 | 95 | 306 |
| Cash | 1.203 | 739 | 179 | 25 | 53 | 113 | 648 | 852 | 483 | 780 |
| Shareholders Funds | -7.153 | -16.400 | -20.864 | -20.327 | -14.553 | -12.715 | -9.983 | -9.718 | -8.679 | -11.631 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.206 | 19.632 | 31.814 | 27.845 | 19.003 | 15.673 | 11.938 | 11.002 | 9.954 | 13.344 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Topoprim S.r.l.